RxDoctor Payments Data

Ryan Williams, PA

Physician Assistant · Moses Lake, WANPI 1770818361

Payments from drug & device makers

$3,192in general payments, 2019–2025

Across 210 payments — averaging $15.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Boston Scientific$639
  • Nalu Medical, Inc.$636
  • Abbott$346
  • Nevro Corp.$117
  • Medtronic$75
  • plus $365 from 12 others

What the payments were for

  • Food & beverage$3,178100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,192 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Medicare billing

Part B allowed, 2024
$91,791
Medicare patients
241
Services billed
1,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine116$36,624
Pregabalin385$22,169
OxycontinOxycodone Hcl30$20,836
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen724$19,253
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen762$17,926
MovantikNaloxegol Oxalate21$11,737
GraliseGabapentin12$11,007
BelbucaBuprenorphine Hcl13$9,382
Celecoxib115$8,394
BelsomraSuvorexant18$7,733
Ajovy SyringeFremanezumab-Vfrm11$7,725
Gabapentin447$7,603
Fentanyl51$5,418
Oxycodone Hcl248$4,371
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$3,354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Redhill Biopharma Inc.Movantik$13$11,73721 claims
MerckBelsomra$56$7,73318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Moses Lake

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →